ILSI-Biomed 2009 attracted 6,000 industry players, engineers and scientists, with 800 participants from 35 countries and more than 2,500 one-on-one meetings. This year’s 9th annual ILSI-Biomed event will build on the great reputation established over the past decade by offering participants a winning mix of keynote industry speakers, medical device and biopharma company presentations, and three days of exhibition and exclusive networking opportunities.
Israel Life Sciences overview 2010
ILSI Biomed Conference highlights
The ILSI-Biomed 2010 Conference will feature the most acclaimed international speakers discussing the industry’s most pressing topics, such as cardiology, vaccines, oncology, cell therapy, personalized medicine, metabolic diseases, e-health and aesthetic medicine markets.
ILSI Biomed 2010 Conference will focus on:
- The role of innovation, its source – industry or academia? Who will pay for it? – venture capital or large medical and biopharma companies?
- Regulatory changes and their impact on innovation
- Does personalized medicine mean smaller target markets?
- Who is better suited to commercialize future “niche” products? Large players or innovative fully integrated companies. How would it impact business models?
click here for the conference program
our Facebook page here
our Twitter: http://twitter.com/Biomed_Israel
israeltrade.org.au 
